Suppr超能文献

重度卵巢过度刺激综合征:我们能否通过多管齐下的方法消除它?

Severe ovarian hyperstimulation syndrome: Can we eliminate it through a multipronged approach?

作者信息

Naredi Nikita, Singh S K, Lele Prasad, Nagraj N

机构信息

Classified Specialist (Obst & Gynae) & IVF Specialist, Assisted Reproductive Technology Centre, Command Hospital (Southern Command), Pune 411040, India.

Classified Specialist (Obst & Gynae), Command Hospital (Southern Command), Pune 411040, India.

出版信息

Med J Armed Forces India. 2018 Jan;74(1):44-50. doi: 10.1016/j.mjafi.2017.04.006. Epub 2017 Jun 19.

Abstract

BACKGROUND

Prevention of severe Ovarian Hyperstimulation Syndrome (OHSS), a potentially fatal complication of controlled ovarian hyperstimulation has been the aim of all fertility experts. Various pharmacologic and non-pharmacologic interventions have been instituted but the results have been conflicting. These preventive strategies were administered in isolation or as a combination of few aiming to eliminate this iatrogenic sequel. This study aimed to eliminate severe OHSS by multipronged approach incorporating almost all preventive modalities available in patients at high risk for this dreadful complication.

METHODS

It was a prospective observational study wherein 112 high risk patients planned for IVF were studied. The multipronged approach was in the form administering calcium gluconate infusion, cabergoline, albumin infusion, GnRH antagonist in luteal phase in addition to elective cryopreservation of embryos. The primary outcome measure was incidence of severe OHSS in the study group and the rate of hospitalisation. The secondary outcome measure was the number of days required for complete recovery and resolution of signs and symptoms.

RESULTS

Out of the 112 high risk patients only one patient (1/112; 0.9%) developed severe OHSS with an overall incidence of 0.095% of severe OHSS in all the cycles. There was no biochemical or haematological derangement in any of the high risk patients.

CONCLUSION

Although this is the first study evaluating the multipronged approach in preventing the dreaded complication of severe OHSS, it does add to the knowledge that targeting the various pathophysiological pathways at different time frames will bring about prevention of OHSS but further randomised studies may reveal superiority of one intervention over the other.

摘要

背景

预防严重卵巢过度刺激综合征(OHSS)是所有生殖专家的目标,OHSS是控制性卵巢刺激的一种潜在致命并发症。已经采取了各种药物和非药物干预措施,但结果相互矛盾。这些预防策略单独使用或几种联合使用,旨在消除这种医源性后遗症。本研究旨在通过多管齐下的方法消除严重OHSS,该方法纳入了几乎所有针对这种可怕并发症的高危患者可用的预防方式。

方法

这是一项前瞻性观察性研究,研究对象为112例计划进行体外受精的高危患者。多管齐下的方法包括静脉输注葡萄糖酸钙、使用卡麦角林、输注白蛋白、黄体期使用促性腺激素释放激素(GnRH)拮抗剂以及选择性冷冻胚胎。主要观察指标是研究组中严重OHSS的发生率和住院率。次要观察指标是完全康复以及体征和症状消失所需的天数。

结果

在112例高危患者中,只有1例患者(1/112;0.9%)发生了严重OHSS,在所有周期中严重OHSS的总体发生率为0.095%。所有高危患者均未出现生化或血液学紊乱。

结论

虽然这是第一项评估多管齐下方法预防严重OHSS这一可怕并发症的研究,但它确实增加了我们的认识,即针对不同时间框架内的各种病理生理途径将预防OHSS,但进一步的随机研究可能会揭示一种干预措施相对于另一种的优越性。

相似文献

1
Severe ovarian hyperstimulation syndrome: Can we eliminate it through a multipronged approach?
Med J Armed Forces India. 2018 Jan;74(1):44-50. doi: 10.1016/j.mjafi.2017.04.006. Epub 2017 Jun 19.
2
Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study.
J Obstet Gynaecol. 2022 Jan;42(1):122-126. doi: 10.1080/01443615.2020.1870944. Epub 2021 Jul 16.
4
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Cochrane Database Syst Rev. 2016 Nov 30;11(11):CD008605. doi: 10.1002/14651858.CD008605.pub3.
5
Volume expanders for the prevention of ovarian hyperstimulation syndrome.
Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD001302. doi: 10.1002/14651858.CD001302.pub3.
7
Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
Cochrane Database Syst Rev. 2002(2):CD002806. doi: 10.1002/14651858.CD002806.
8
Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome.
J Gynecol Obstet Hum Reprod. 2017 Jan;46(1):87-91. doi: 10.1016/j.jgyn.2016.04.002. Epub 2016 May 27.
9
Calcium gluconate infusion is not as effective as dopamine agonists in preventing ovarian hyperstimulation syndrome.
Eur Rev Med Pharmacol Sci. 2022 Feb;26(4):1248-1254. doi: 10.26355/eurrev_202202_28117.
10
Use of cabergoline and post-collection GnRH antagonist administration for prevention of ovarian hyperstimulation syndrome.
Reprod Biomed Online. 2019 Sep;39(3):433-438. doi: 10.1016/j.rbmo.2019.04.014. Epub 2019 Apr 25.

引用本文的文献

1
Ovarian Hyperstimulation Syndrome (OHSS) requiring Intensive Care Unit (ICU) admission between 1996-2020 in England, Wales, and Northern Ireland.
Front Endocrinol (Lausanne). 2022 Dec 15;13:1060173. doi: 10.3389/fendo.2022.1060173. eCollection 2022.

本文引用的文献

1
Predictive factors for recovery time in patients suffering from severe OHSS.
Reprod Biol Endocrinol. 2014 Jul 5;12:59. doi: 10.1186/1477-7827-12-59.
2
Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
Hum Reprod. 2013 Jul;28(7):1929-42. doi: 10.1093/humrep/det114. Epub 2013 Apr 26.
5
New algorithm for OHSS prevention.
Reprod Biol Endocrinol. 2011 Nov 3;9:147. doi: 10.1186/1477-7827-9-147.
6
Current status of human oocyte and embryo cryopreservation.
Curr Opin Obstet Gynecol. 2011 Aug;23(4):245-50. doi: 10.1097/GCO.0b013e32834874e2.
8
Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome.
Cochrane Database Syst Rev. 2011 Feb 16(2):CD001302. doi: 10.1002/14651858.CD001302.pub2.
9
Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists.
Semin Reprod Med. 2010 Nov;28(6):493-9. doi: 10.1055/s-0030-1265676. Epub 2010 Nov 16.
10
Physiology and pathology of ovarian hyperstimulation syndrome.
Semin Reprod Med. 2010 Nov;28(6):448-57. doi: 10.1055/s-0030-1265670. Epub 2010 Nov 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验